IL6 and endothelial dysfunction: Elevated levels of pro-inflammatory cytokines, such as tumour necrosis factor-alpha (TNF-alpha), interleukin-1 (IL-1), and interleukin-6 (IL-6), contribute to endothelial dysfunction by reducing the bioavailability of nitric oxide, increasing oxidative stress, and impairing vasodilation.